Gastric emptying and the pharmacokinetics of the cephalosporin antibiotic, cefpodoxime proxetil
- PMID: 2352449
Gastric emptying and the pharmacokinetics of the cephalosporin antibiotic, cefpodoxime proxetil
Abstract
The effects of gastric motility on the pharmacokinetics of cefpodoxime proxetil, an oral, broad spectrum, third-generation cephalosporin antibiotic were evaluated in 12 healthy subjects. In this open-label, crossover trial, each subject took a 200 mg dose (two 100 mg film-coated tablets) in each study period. There was an initial fasting period followed by a control period and then either a propantheline or metoclopramide period. Gastric motility was measured using [99mTc]-labeled sulfur colloid in oatmeal in the control, propantheline and metoclopramide periods. Treatment with propantheline or metoclopramide was given 30 min before dosing with the antibiotic and the radioisotope. Serial images with a gamma counter were made every 15 min for 2 h. Gastric emptying time was faster than control with metoclopramide, but generally slower with propantheline than control. The mean peak plasma concentration, mean area under plasma concentration time curve and mean half-life of cefpodoxime proxetil were similar in all groups as compared to control. The mean time to peak plasma concentration was delayed in the propantheline period and peak plasma concentrations were greater at all sampling times at six hours after dosing. This study utilized the gastric nuclear scan with modification of gastric motility by metoclopramide and propantheline and with simultaneous determination of the disposition of cefpodoxime proxetil to understand the absorption of the drug.
Similar articles
-
A review of the pharmacokinetics of cefpodoxime proxetil.Drugs. 1991;42 Suppl 3:13-21. doi: 10.2165/00003495-199100423-00005. Drugs. 1991. PMID: 1726203 Review.
-
Effect of altered gastric emptying and gastrointestinal motility on metformin absorption.Br J Clin Pharmacol. 2000 Oct;50(4):325-32. doi: 10.1046/j.1365-2125.2000.00264.x. Br J Clin Pharmacol. 2000. PMID: 11012555 Free PMC article. Clinical Trial.
-
The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil.Clin Pharmacol Ther. 1989 Dec;46(6):674-85. doi: 10.1038/clpt.1989.204. Clin Pharmacol Ther. 1989. PMID: 2557183 Clinical Trial.
-
Pharmacokinetic interactions of cefprozil with food, propantheline, metoclopramide, and probenecid in healthy volunteers.J Clin Pharmacol. 1992 Aug;32(8):725-31. doi: 10.1002/j.1552-4604.1992.tb03876.x. J Clin Pharmacol. 1992. PMID: 1487562
-
Drugs, diseases and altered gastric emptying.Clin Pharmacokinet. 1976;1(3):189-203. doi: 10.2165/00003088-197601030-00002. Clin Pharmacokinet. 1976. PMID: 797497 Review.
Cited by
-
Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.Paediatr Drugs. 2001;3(2):137-58. doi: 10.2165/00128072-200103020-00006. Paediatr Drugs. 2001. PMID: 11269640 Review.
-
Pharmacokinetics and ex vivo susceptibility of cefpodoxime proxetil in patients receiving continuous ambulatory peritoneal dialysis.Antimicrob Agents Chemother. 1993 Dec;37(12):2650-5. doi: 10.1128/AAC.37.12.2650. Antimicrob Agents Chemother. 1993. PMID: 8109931 Free PMC article.
-
Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.Drugs. 1992 Nov;44(5):889-917. doi: 10.2165/00003495-199244050-00011. Drugs. 1992. PMID: 1280571 Review.
-
A review of the pharmacokinetics of cefpodoxime proxetil.Drugs. 1991;42 Suppl 3:13-21. doi: 10.2165/00003495-199100423-00005. Drugs. 1991. PMID: 1726203 Review.
-
Cefpodoxime proxetil in upper respiratory tract infections.Drugs. 1991;42 Suppl 3:25-33. doi: 10.2165/00003495-199100423-00007. Drugs. 1991. PMID: 1726205 Review.